WHO to send 200 million doses of H1N1 flu vaccine to poor countries

October 29, 2009 02:29 pm | Updated November 17, 2021 06:44 am IST - Havana

Director General of the World Health Organization, WHO, China's Dr. Margaret Chan, attends a press conference in Havana, Wednesday, Oct. 28, 2009. Photo: Emilo Herrera

Director General of the World Health Organization, WHO, China's Dr. Margaret Chan, attends a press conference in Havana, Wednesday, Oct. 28, 2009. Photo: Emilo Herrera

The World Health Organization (WHO) plans to send 200 million doses of vaccine for the H1N1 influenza virus to about 100 developing countries, WHO Director-General, Margaret Chan, said on Wednesday, in Havana.

In a press conference at the end of her visit to Cuba, Dr. Chan admitted that vaccine production capacity is limited, but said the WHO is working alongside UN Secretary General Ban Ki-moon to get manufacturers and other stakeholders to make vaccines available to poor countries.

Chan said the commitment they had obtained so far was to make 200 doses of vaccine available to the WHO within the coming year, and that the organization would send the medication on to developing countries, including Cuba.

The head of the WHO said that one dose would be enough for adults, while children under 10 would require two doses to be protected against the so-called swine flu virus. Chan noted that 25 manufacturers around the world were producing the vaccine, although not all clinical tests were complete yet.

She stressed that the WHO is promoting measures to combat the virus beyond pharmaceutical methods, from simple hand washing to education about respiratory diseases. Hygiene, information and vaccines are complementary, she said.

Chan added that the WHO has sent doses of the antiviral drug Tamiflu to 121 developing Nations, which is widely used to treat H1N1 patients.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.